id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-N-0464-0008,FDA,FDA-2005-N-0464,"Notice of Extension re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs; Public Meeting; Extension of Comment Period",Proposed Rule,Extension of Comment Period,2006-10-31T05:00:00Z,2006,10,2006-10-30T05:00:00Z,2007-01-27T04:59:59Z,2016-12-19T17:17:44Z,,0,0,0900006480450c15
FDA-2005-N-0464-0006,FDA,FDA-2005-N-0464,"REF 1 - OMB Changes re The September 30, 1993, Executive Order 12866 (E.O.) --Regulatory Planning and Review sets forth the Administration's principles and requirements for the Federal regulatory process",Supporting & Related Material,REF-Reference (internal unless indicated),2006-09-08T04:00:00Z,2006,9,,,2017-07-24T14:15:25Z,,0,0,0900006480450c08
FDA-2005-N-0464-0005,FDA,FDA-2005-N-0464,"REF 1 - OMB Changes re The September 30, 1993, Executive Order 12866 (E.O.) --Regulatory Planning and Review sets forth the Administration's principles and requirements for the Federal regulatory process",Supporting & Related Material,REF-Reference (internal unless indicated),2006-09-08T04:00:00Z,2006,9,,,2017-07-24T14:17:07Z,,0,0,0900006480450c07
FDA-2005-N-0464-0007,FDA,FDA-2005-N-0464,"REF 1 - OMB Changes re The September 30, 1993, Executive Order 12866 (E.O.) --Regulatory Planning and Review sets forth the Administration's principles and requirements for the Federal regulatory process",Supporting & Related Material,REF-Reference (internal unless indicated),2006-09-08T04:00:00Z,2006,9,,,2017-07-24T14:12:42Z,,0,0,0900006480450c09
FDA-2005-N-0464-0002,FDA,FDA-2005-N-0464,"Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 201-300)",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-08-23T04:00:00Z,2006,8,2006-08-23T04:00:00Z,2006-11-28T04:59:59Z,2017-08-15T14:33:55Z,,0,0,0900006480450bee
FDA-2005-N-0464-0001,FDA,FDA-2005-N-0464,"Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 301-319)",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-08-23T04:00:00Z,2006,8,2006-08-23T04:00:00Z,2006-11-28T04:59:59Z,2017-08-15T14:32:51Z,,0,0,0900006480450bce
FDA-2005-N-0464-0003,FDA,FDA-2005-N-0464,"Proposed rule on Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 1-100)",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-08-23T04:00:00Z,2006,8,2006-08-23T04:00:00Z,2006-11-28T04:59:59Z,2017-08-15T14:35:39Z,,0,0,0900006480450bf2
FDA-2005-N-0464-0004,FDA,FDA-2005-N-0464,"Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under a Biologics License Application, and Animal Drugs (Pages 101-200)",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2006-08-23T04:00:00Z,2006,8,2006-08-23T04:00:00Z,2006-11-28T04:59:59Z,2016-03-14T19:19:42Z,,0,0,0900006480450bf3